CMS Announces Plans to Pursue New Medicare and Medicaid Drug Payment Models
This week our In Focus section reviews the Centers for Medicare and Medicaid Services’ (CMS) announcement that the agency will explore three new prescription drug payment models in the Medicare and Medicaid programs:
• Medicare High-Value Drug List Model
• Cell and Gene Therapy (CGT) Access Model
• Accelerating Clinical Evidence Model
Every Wednesday, HMA publishes the Weekly Roundup, an information-packed resource that will keep you updated on industry news, trends in state health policy throughout the nation, and more.